Short-, Medium-, and Long-Term Cardiometabolic Outcomes in First-Episode Psychosis: A Systematic Review and Meta-analysis
Schizophrenia Bulletin · 07.03.2026 · 52 (2)
DOI: 10.1093/schbul/sbag008 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Schizophrenia Bulletin, online erschienen am 21.03.2026. Verfasst von Anna Zierotin und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin 4, D04 V1W8, Ireland. Hauptthemen laut MEDLINE: Psychotic Disorders, Metabolic Syndrome, Cardiovascular Diseases, Antipsychotic Agents. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Board Psychosis Ireland Structured Training and Research, Taighde Éireann - Research Ireland, FutureNeuro Research Ireland Centre for Translational Brain Science.
Abstract (Originalsprache)
Background
Individuals with first-episode psychosis (FEP) experience increased cardiometabolic risks, contributing to reduced life expectancy. While metabolic disturbances are well described in chronic schizophrenia, their trajectory from first presentation, before or with minimal antipsychotic exposure, through to long-term follow-up remains incompletely characterized.
Objective
To synthesize evidence on progression of cardiometabolic outcomes in FEP cohorts from before initiation of antipsychotic medication to up to 10 years of follow-up. Study Design Following PRISMA and MOOSE guidelines (PROSPERO: CRD42023431072), Medline, Embase, PsycInfo, and CINAHL+ were searched to July 2025 for studies of FEP cohorts with ≤28 days of antipsychotic exposure at baseline. Outcomes included weight, glucose, lipids, blood pressure, metabolic syndrome (MetS), diabetes, and cardiovascular disease (CVD). Random-effects meta-analyses were stratified by follow-up duration. As post-baseline exposure was not quantified, follow-up estimates reflect outcomes under routine care. Study Results From 2601 unique articles, 82 studies were included. Obesity and MetS prevalence increased from 5.4% and 8.5%, respectively at baseline, to 26.6% and 18.2% at 1–3 years, whereas type 2 diabetes increased from 0.5% to 5.0% by >5 years. Lipid abnormalities emerged early, while blood pressure changes were minimal, and CVD hospitalization prevalence was 1.4% at 5–10 years. Weight increased by +2.5 kg at 4–8 weeks and + 13.4 kg at >5 years, with parallel increases in BMI and waist circumference.
Conclusions
Cardiometabolic deterioration begins within weeks of FEP onset and accumulates over time, indicating the need for early prevention, sustained monitoring, integrated metabolic care, and patient education throughout the course of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Dublin 4, D04 V1W8, Ireland.
- Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin 2, DO2 YN77, Ireland.
- Max Planck Institute for Human Development, Center for Environmental Neuroscience, 14195 Berlin, Germany.
- Recovery and Engagement Lead, Office of Mental Health Engagement and Recovery, HSE, Dublin, D20 HK69, Ireland.
- FutureNeuro Research Ireland Centre, RCSI University of Medicine and Health Sciences, Dublin 2, D02 YN77, Ireland.
- Department of Psychiatry, Beaumont Hospital, Dublin, D09 V2N0, Ireland.
ORCID-Profile: Anna Zierotin, Michael John Norton, Brian O'Donoghue
Förderung
- Health Research Board Psychosis Ireland Structured Training and Research
- Taighde Éireann - Research Ireland
- FutureNeuro Research Ireland Centre for Translational Brain Science
- Taighde Éireann – Research Ireland
Zitieren
APA
Zierotin, A., Murphy, J., Stano, A., Norton, M. J., Cotter, D. R., Cannon, M., O'Connor, K., O'Donoghue, B., & Clarke, M. (2026). Short-, Medium-, and Long-Term Cardiometabolic Outcomes in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophrenia Bulletin, 52(2). https://doi.org/10.1093/schbul/sbag008
Vancouver
Zierotin A, Murphy J, Stano A, Norton MJ, Cotter DR, Cannon M, et al. Short-, Medium-, and Long-Term Cardiometabolic Outcomes in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. 2026;52(2). doi:10.1093/schbul/sbag008
BibTeX
@article{Zierotin2026,
author = {Zierotin, Anna and Murphy, Jennifer and Stano, Anja and Norton, Michael John and Cotter, David R and Cannon, Mary and O'Connor, Karen and O'Donoghue, Brian and Clarke, Mary},
title = {Short-, Medium-, and Long-Term Cardiometabolic Outcomes in First-Episode Psychosis: A Systematic Review and Meta-analysis},
journal = {Schizophrenia Bulletin},
year = {2026},
volume = {52},
number = {2},
doi = {10.1093/schbul/sbag008}
}
EUVIMED